Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Clinical trial NCT01489423 · COMPLETED
Trial details
- NCT number
- NCT01489423
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-26
- Primary completion
- 2013-05-26
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.